참고문헌
- Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G, and Sigman CC : Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomarkers Prev., 1995 ; 4 :1-10.
- Ames BN, Gold LS, and Willett WC : The causes and prevention of cancer. Proc. Natl. Acad. Sci. U. S. A., 1995 ; 92 : 5258-5265.
- Ammon HP, and Wahl MA : Pharmacology of Curcuma longa. Planta. Med., 1991 ; 57 :1-7.
- Huang MT, Smart RC, Wong CQ, and Conney AH : Inhibitory effect of curcumin, chlorogenic acid, caffeicacid, and ferulic acid on tumor promotion in mouse skin by\12-O-tetradecanoylphor bol-13-acetate. Cancer Res., 1998 ; 48 : 5941-5946.
- Huang MT, Newmark HL, and Frenkel K : Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl., 1997 ; 27 : 26-34.
- Soleas, GJ., Diamandis, EP., and Goldberg, DM. : Wine as a biological fluid:history, production, and role in disease prevention. J. Clin. Lab. Anal., 1997 ; 11: 287-313.
- Soleas, GJ., Diamandis, EP., and Goldberg, DM. : Resveratrol: a molecule whose time has come? And gone? Clin. Biochem., 1997 ; 30 : 91-113.
- Fremont, L. : Biochemical effect of resveratrol. Life Sci., 2000 ; 66 : 6663-6673.
- Jang, M., Cai, L., Udeani, GO., Slowing, KV., Thomas, CF., Beecher, CW. Fong, HH., Farnsworth, NR., Kinghorn, AD., Mehta, RG., Moon, RC., and Pezzuto, JM. : Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997 ; 275 : 218-220. https://doi.org/10.1126/science.275.5297.218
- Fauconneau, B., Waffo-Teguo, P., Huguet, F. Barrier, L., Decendit, A., and Merillon, JM. : Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci., 1997 ; 61 : 2103-2110.
- Pace-Asciak, CR., Rounova, O., Hahn, SE., Diamandis, EP., and Goldberg, DM. : The red wine phenolics trans resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis :Implication for protection against coronary heart disease. Clin. Chim. Acta., 1996 ; 246 :163-182.
- Mgbonyebi, OP., Russo, J., and Russo, IH. : Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 1998 ; 12 : 865-869.
- Clement, MV., Hirpara, JL., Vhawdhury, SH., and Pervaiz, S. : Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998 ; 92: 996-1002.
- Surh, YJ., Hurh, YJ., Kang, JY., Lee, E., Kong, G., and Lee, SJ. : Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL60) cells. Cancer letters, 1999 ; 140:1-10. https://doi.org/10.1016/S0304-3835(99)00039-7
- Ragione, FD., Cucciolla, V., Borriello, A., Pietra, VD., Racioppi, L., Soldati, G., Manna, C., Galletti, P., and Zappia, V. : Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun., 1998 ; 250: 53-58.
- Hunter, T. and Pines, J. : Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 1994 ; 79: 573-82.
- Morgan, DO. : Principles of CDK regulation. Nature, 1995 ; 374: 131-134. https://doi.org/10.1038/374131a0
- Sherr, CJ. and Roberts, JM. : Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev. 1995 ; 9: 1149-1163.
- Ikeda, MA., Jakoi, L. and Nevins, JR. : A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 1996 ; 93: 3215-3220.
- Moberg, K., Starz, MA. and Lees, JA. : E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 1996 ; 16: 1436-1449.
- Wyllie, AH. : Apoptosis. Br. J. Cancer, 1993 ; 67: 205-208.
- Thompson, CB. : Apoptosis in the pathogenesis and treatment of disease. Science, 1995 ; 267: 1456-1462. https://doi.org/10.1126/science.7878464
- Tsujimoto, Y., Jaffe, E., Cossman, J., Gorham, J., Nowell, PC. and Croce, CM. : Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature, 1985 ; 315: 340-343.
- Tsujimoto, Y. and Croce, CM. : Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. U. S. A. 1986 ; 83: 5214-5218.
- Lawrence, MS., Ho, DY., Sun, GH.,Steinberg, GK. and Sapolsky, RM. : Over expression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci., 1996 ; 16: 486-496.
- Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H. and Tsujimoto, Y. : Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature, 1995 ; 374: 811-813.
- Tudor, G., Aguilera, A,. Halverson, DO. ,Laing, ND. and Sausville, EA. : Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ., 2000 ; 7: 574-586.
- illardon, F., Moll, I., Meyer, M. and Michaelidis, TM. : Alterations in cell death and cell cycle progression in the UV-irradiated epidermis of bcl-2-deficient mice. Cell Death Differ., 1999 ; 6: 55-60.
- Kyprianou, N., King, ED., Bradbury, D. and Rhee, JG. : bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int. J. Cancer, 1997 ; 70: 341-348.
- Yang, J., Liu, X., Bhalla, K., Kim, CN., Ibrado, AM., Cai, J., Peng, TI., Jones, DP. and Wang, X. : Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 1997 ; 275: 1129-1132.
- Kluck, RM., Bossy-Wetzel, E., Green, DR. and Newmeyer, DD. : The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 1997 ; 275: 1132-1136.
- Koriyama, H., Kouchi, Z., Umeda, T., Saido, TC., Momoi, T., Ishiura, S. and Suzuki, K. : Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cell Signal., 1999 ; 11: 831-838.
- Park, JW., Choi, YJ., Suh, SI., Baek, WK., Suh, MH., Jin, IN., Min, DS., Woo, JH., Chang, JS., Passaniti, A., Lee, YH. and Kwon, TK. : Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis, 2001 ; 22: 1633-1639.
- Mashima, T., Naito, M., Noguchi, K., Miller, DK., Nicholson, DW. and Tsuruo, T.: Actin cleavage byCPP-32/apopain during the development of apoptosis. Oncogene, 1997 ; 14: 1007-1012.
- Decker, P., Isenberg, D. and Muller, S. : Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J. Biol. Chem., 2000 ; 275: 9043-9046.
- An, B. and Dou, QP. : Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res., 1996 ; 56: 438-442.
- Zhang, Y., Fujita, N. and Tsuruo, T. : Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 1999 ; 18: 1131-1138.
- John, A. and Tuszynski, G. : The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res., 2001 ; 7: 14-23.
- Stamenkovic, I. : Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 2000 ; 10: 415-433.
- Curran, S. and Murray, G. I. : Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer, 2000 ; 36: 1621-1630.
- Nelson, AR., Fingleton, B., Rothenberg, ML. and Matrisian, LM. : Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 2000 ; 18: 1135-4119.
- Park, JW., Choi, YJ., Jang, MA., Lee, YS., Jun, DY., Suh, SI., Baek, WK., Suh, MH., Jin, IN. and Kwon, TK. : Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett., 2001 ; 163: 43-49.
- Chung, LY., Cheung, TC., Kong, SK., Fung, KP., Choy, YM., Chan, ZY. and Kwok, TT. : Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci., 2001 ; 68: 1207-1214.
- Islam, S., Islam, N., Kermode, T., Johnstone, B., Mukhtar, H., Moskowitz, RW., Goldberg, VM., Malemud, CJ. and Haqqi, TM. : Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells Biochem. Biophys. Res. Commun., 2000 ; 270:793-797.
- Grutter, MG. : Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol., 2000 ; 10: 649-655.
- Nunez, G., Benedict, MA., Hu, Y. and Inohara. N. : Caspases: the proteases of the apoptotic pathway. Oncogene, 1998 ; 17: 3237-3245.
- Srinivasula, SM., Ahmad, M., Fernandes-Alnemri, T. and Alnemri, ES. :Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell, 1998 ; 1: 949-957.
- Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, SM., Ahmad, M., Alnemri, ES. and Wang, X. : Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997 ; 91: 479-489.